Conduction system pacing was found to be inferior to biventricular pacing for key outcomes in HFrEF with left bundle-branch ...

The findings suggest that use of the pacing technique during CRT should be reserved for expert operators, at least for now.

Medtronic and Biotronik both took steps forward this week with their pacemaker hardware designed to target newly emerging ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) ...

Medtronic announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.

The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate ...

Physiologic pacing of the His-Purkinje conduction system is feasible in patients who require a permanent pacemaker following TAVR and this alternative pacing method did not interfere with ejection ...

Medtronic snagged FDA approval for an expanded indication for its OmniaSecure defibrillation lead. Check out why this tiny ...

NEW ORLEANS -- Among patients with heart failure, conduction system pacing-guided cardiac resynchronization therapy was associated with improvements in left ventricular ejection fraction (LVEF) ...

Please provide your email address to receive an email when new articles are posted on . Left bundle branch pacing was achieved for the first time via leadless pacemaker. Implantation failure rate was ...

Please provide your email address to receive an email when new articles are posted on . Medtronic announced its cardiac lead received an expanded indication from the FDA for left bundle branch area ...